ZTS Zoetis Inc

Price (delayed)

$203.59

Market cap

$96.66B

P/E Ratio

54.58

Dividend/share

$0.95

EPS

$3.73

Enterprise value

$100.41B

Zoetis Inc. is the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's ...

Highlights
ZTS's equity is up by 49% year-on-year and by 8% since the previous quarter
Zoetis's quick ratio has increased by 36% YoY and by 8% QoQ
The P/E is 43% higher than the 5-year quarterly average of 38.2 and 23% higher than the last 4 quarters average of 44.5
The debt rose by 11% YoY

Key stats

What are the main financial stats of ZTS
Market
Shares outstanding
474.77M
Market cap
$96.66B
Enterprise value
$100.41B
Valuations
Price to earnings (P/E)
54.58
Price to book (P/B)
23.66
Price to sales (P/S)
13.81
EV/EBIT
41.42
EV/EBITDA
35.06
EV/Sales
14.32
Earnings
Revenue
$7.01B
EBIT
$2.42B
EBITDA
$2.86B
Free cash flow
$1.68B
Per share
EPS
$3.73
Free cash flow per share
$3.54
Book value per share
$8.61
Revenue per share
$14.75
TBVPS
$19.81
Balance sheet
Total assets
$13.8B
Total liabilities
$9.7B
Debt
$7.35B
Equity
$4.09B
Working capital
$4.73B
Liquidity
Debt to equity
1.8
Current ratio
3.29
Quick ratio
2.29
Net debt/EBITDA
1.31
Margins
EBITDA margin
40.8%
Gross margin
69.4%
Net margin
25.3%
Operating margin
34.5%
Efficiency
Return on assets
13.1%
Return on equity
49.1%
Return on invested capital
21.9%
Return on capital employed
20.7%
Return on sales
34.6%
Dividend
Dividend yield
0.47%
DPS
$0.95
Payout ratio
25.5%

ZTS stock price

How has the Zoetis stock price performed over time
Intraday
1.52%
1 week
1.96%
1 month
9.39%
1 year
41.31%
YTD
23.02%
QTD
9.25%

Financial performance

How have Zoetis's revenue and profit performed over time
Revenue
$7.01B
Gross profit
$4.87B
Operating income
$2.42B
Net income
$1.77B
Gross margin
69.4%
Net margin
25.3%
Zoetis's operating income has increased by 13% YoY and by 9% QoQ
ZTS's revenue is up by 11% YoY and by 5% QoQ
The gross profit has grown by 10% YoY and by 5% from the previous quarter
The net income has grown by 10% YoY and by 8% from the previous quarter

Growth

What is Zoetis's growth rate over time

Valuation

What is Zoetis stock price valuation
P/E
54.58
P/B
23.66
P/S
13.81
EV/EBIT
41.42
EV/EBITDA
35.06
EV/Sales
14.32
The P/E is 43% higher than the 5-year quarterly average of 38.2 and 23% higher than the last 4 quarters average of 44.5
Zoetis's EPS has increased by 10% YoY and by 8% QoQ
ZTS's equity is up by 49% year-on-year and by 8% since the previous quarter
The stock's price to book (P/B) is 19% more than its 5-year quarterly average of 19.8 and 14% more than its last 4 quarters average of 20.7
ZTS's price to sales (P/S) is 68% higher than its 5-year quarterly average of 8.2 and 23% higher than its last 4 quarters average of 11.2
ZTS's revenue is up by 11% YoY and by 5% QoQ

Efficiency

How efficient is Zoetis business performance
The company's return on equity fell by 20% YoY
ZTS's return on assets is down by 8% year-on-year but it is up by 4% since the previous quarter
ZTS's ROIC is up by 6% QoQ and by 4.8% YoY
Zoetis's return on sales has increased by 3.6% QoQ and by 2.7% YoY

Dividends

What is ZTS's dividend history
DPS
$0.95
Dividend yield
0.47%
Payout ratio
25.5%
Recent dividends

Financial health

How did Zoetis financials performed over time
ZTS's total assets is 42% greater than its total liabilities
Zoetis's quick ratio has increased by 36% YoY and by 8% QoQ
ZTS's total assets is up by 20% year-on-year
The debt is 80% higher than the equity
ZTS's equity is up by 49% year-on-year and by 8% since the previous quarter
Zoetis's debt to equity has decreased by 25% YoY and by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.